Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 1006 AL 1020

Postgenomics, uncertain futures, and the familiarization of susceptibility genes

Chilibeck G, Lock M, Sehdev M.

Soc Sci Med. 2011 Jun;72(11):1768-75. doi: 10.1016/j.socscimed.2010.01.053. Epub 2010 May 8.

Mechanisms of AD neurodegeneration may be independent of Aβ and its derivatives

Robakis NK.

Neurobiol Aging. 2011 Mar;32(3):372-9. doi: 10.1016/j.neurobiolaging.2010.05.022. Epub 2010 Jul 1.

Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease

Bergvall N, Brinck P, Eek D, Gustavsson A, Wimo A, Winblad B, Jönsson L.

Int Psychogeriatr. 2011 Feb;23(1):73-85. doi: 10.1017/S1041610210000785. Epub 2010 Jul 12.

Mitochondrial dysfunction and Alzheimer's disease

Maruszak A, Żekanowski C.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):320-30. doi: 10.1016/j.pnpbp.2010.07.004. Epub 2010 Jul 16.

Novel insights for the treatment of Alzheimer's disease

Kurz A, Perneczky R.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):373-9. doi: 10.1016/j.pnpbp.2010.07.018. Epub 2010 Jul 23.

Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease

Manev H, Chen H, Dzitoyeva S, Manev R.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):315-9. doi: 10.1016/j.pnpbp.2010.07.032. Epub 2010 Aug 5.

Drosophila as a model to study age-related neurodegenerative disorders: Alzheimer's disease

Bonner JM, Boulianne GL.

Exp Gerontol. 2011 May;46(5):335-9. doi: 10.1016/j.exger.2010.08.004. Epub 2010 Aug 16.

Alzheimer's disease: effects of β-amyloid on mitochondria

Tillement L, Lecanu L, Papadopoulos V.

Mitochondrion. 2011 Jan;11(1):13-21. doi: 10.1016/j.mito.2010.08.009. Epub 2010 Sep 15.

Hippocampal morphometry in population-based incident Alzheimer's disease and vascular dementia: the HAAS

Scher AI, Xu Y, Korf ES, Hartley SW, Witter MP, Scheltens P, White LR, Thompson PM, Toga AW, Valentino DJ, Launer LJ.

J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):373-6. doi: 10.1136/jnnp.2008.165902. Epub 2010 Sep 8.

Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative

Villard V, Espallergues J, Keller E, Vamvakides A, Maurice T.

J Psychopharmacol. 2011 Aug;25(8):1101-17. doi: 10.1177/0269881110379286. Epub 2010 Sep 9.

Docking of the alkaloid geissospermine into acetylcholinesterase: a natural scaffold targeting the treatment of Alzheimer's disease

Araújo JQ, Lima JA, Pinto Ada C, de Alencastro RB, Albuquerque MG.

J Mol Model. 2011 Jun;17(6):1401-12. doi: 10.1007/s00894-010-0841-2. Epub 2010 Sep 16.

Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models

Nagy B, Brennan A, Brandtmüller A, Thomas SK, Sullivan SD, Akehurst R.

Int J Geriatr Psychiatry. 2011 May;26(5):483-94. doi: 10.1002/gps.2551. Epub 2010 Sep 15.

Intranasal insulin as a therapeutic option in the treatment of cognitive impairments

Benedict C, Frey WH 2nd, Schiöth HB, Schultes B, Born J, Hallschmid M.

Exp Gerontol. 2011 Feb-Mar;46(2-3):112-5. doi: 10.1016/j.exger.2010.08.026. Epub 2010 Sep 16.

Patch-based segmentation using expert priors: application to hippocampus and ventricle segmentation

Coupé P, Manjón JV, Fonov V, Pruessner J, Robles M, Collins DL.

Neuroimage. 2011 Jan 15;54(2):940-54. doi: 10.1016/j.neuroimage.2010.09.018. Epub 2010 Sep 17.

Unresolved questions concerning etiology of Alzheimer's disease: hypometabolism

Pluta R.

Nutrition. 2011 Jan;27(1):1-2. doi: 10.1016/j.nut.2010.07.010. Epub 2010 Sep 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias